drugset / Trial / NCT02286531
Evaluation de O-(2-[18F]-Fluoroethyl)-L-Tyrosine, a New Tracer PET, in the Diagnosis of Low Grade Glioma
NaSingle-groupOpen-labelDiagnostic
Summary
Determine the overall discriminatory ability of FET PET in the diagnosis of glioma grade II (referring to the current diagnostic gold standard represented by the histopathology exam of a tumor sample).
Timeline
- Start
- 2010-06
- Primary completion
- 2014-12
- Completion
- 2014-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | O-(2[18F]FLUOROETHYL)-L-TYROSINE | Unknown | 3.7 mbq/kg | Intravenous |